1-6 of 6
Stephen J. Harnicar, PharmD
Close
Sort by
Journal Articles

Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)

Gunjan L. Shah, MD, Andrew Lin, PharmD, Ryan Schofield, MS, Caitlin Sarubbi, AB, Elaina V. Preston, PA-C,MPH, Sean M. Devlin, PhD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Elizabeth Hoover, BS, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD, Heather Landau, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2023.
https://doi.org/10.1182/blood.V130.Suppl_1.2023.2023
Published: 2017
Journal Articles

Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis

Gunjan L. Shah, MD, Heather Landau, MD, Caitlin Sarubbi, A.B, Ryan Schofield, MS, Andrew Lin, PharmD, Valkal Bhatt, PharmD, Stephen J. Harnicar, PharmD, Sean M. Devlin, PhD, David J. Chung, MDPhD, Parastoo B. Dahi, MD, Guenther Koehne, MDPhD, Roni Tamari, MD, Dean Carlow, MDPhD, Sergio A. Giralt, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3296.
https://doi.org/10.1182/blood.V130.Suppl_1.3296.3296
Published: 2017
Journal Articles

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Eva Simona Laube, MD, Anthony Yu, MD, Dipti Gupta, MD MPH, Yimei Miao, BS, Patrick Samedy, MS, Jonathan Wills, BA, Stephen J. Harnicar, PharmD, BCOP, BCPS, Gerald A. Soff, MD, Simon Mantha, MD MPH
Journal: Blood
Blood (2016) 128 (22): 2621.
https://doi.org/10.1182/blood.V128.22.2621.2621
Published: 2016
Journal Articles

Intensified Mycophenolate Mofetil (MMF) Dosing Every 8 Hours Is Safe From The Standpoint Of Engraftment and May Ameliorate Severe Acute Graft-Versus-Host Disease (GVHD) After Double-Unit Cord Blood Transplantation (CBT)

Doris M Ponce, MD, Stephen J. Harnicar, PharmD, BCOP, BCPS, Sean Devlin, PhD, Patrick Hilden, MS, Katherine L Evans, BA, Marissa N Lubin, BA, Sergio A Giralt, MD, Jenna D Goldberg, MD, Miguel-Angel Perales, MD, Nancy A. Kernan, MD, Susan E. Prockop, MD, Andromachi Scaradavou, MD, Juliet N Barker, MBBS, (Hons), FRACP
Journal: Blood
Blood (2013) 122 (21): 4600.
https://doi.org/10.1182/blood.V122.21.4600.4600
Published: 2013
Journal Articles

Higher Mycophenolic Acid (MPA) Trough Levels Result In Lower Day 100 Severe Acute GVHD Without Increased Toxicity In Double-Unit Cord Blood Transplantation (CBT) Recipients

Stephen J. Harnicar, PharmD, BCOP, BCPS, Doris M Ponce, MD, David Gregornik, PharmD, Sherry Mathew, PharmD, BCOP, Katherine L Evans, BA, Junting Zheng, MS, Sean Devlin, PhD, Melissa Pozotrigo, PharmD, BCOP, Andromachi Scaradavou, MD, Nancy A. Kernan, MD, Nelly G. Adel, PharmD, BCOP, BCPS, Juliet N Barker, MBBS, (Hons), FRACP
Journal: Blood
Blood (2013) 122 (21): 3297.
https://doi.org/10.1182/blood.V122.21.3297.3297
Published: 2013
Journal Articles

High Number of Successful Mobilizations Associated with the Use of Plerixafor and Colony Stimulating Factors In Patients with Multiple Myeloma (MM) and Lymphoma Treated at Memorial Sloan-Kettering Cancer Center

Nelly G. Adel, PharmD, Mathew Sherry, Pharm.D., Stephen J. Harnicar, PharmD, Emily Mccullagh, NP, Heather Landau, MD, Sergio Giralt, MD, Jill Vanak, Danielle Chimento, Charles Lucarelli, Matthew J. Matasar, MD, MS, Hani Hassoun, MD
Journal: Blood
Blood (2010) 116 (21): 2263.
https://doi.org/10.1182/blood.V116.21.2263.2263
Published: 2010